Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Breast Cancer, Early Stage

ESMO-Congress-2023-Banner-1000x250px

Friday 20 October

Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates

01-Evolving-Paradigms-in-Hormone-Receptor-Positive-Breast-Cancer-ASTRAZENECA-thumb

Friday, 10:15 - 11:45
View the satellite invitation

Saturday 21 October

Keeping the Outcome in Mind: Applying Best Practices for Managing HR+/HER2- EBC at High Risk of Recurrence

14-Keeping-the-Outcome-in-Mind-MEDSCAPE-Thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Sunday 22 October

Expanding Horizons: Clinical and Patient Perspectives on CDK4/6 Inhibitors in HR+/HER2- Early Breast Cancer

30-Expanding-Horizons-Clinical-and-Patient-Perspectives-on-CDK4-6-NOVARTIS-thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Monday 23 October

HER Future: Pathways to Better Care for Women with HER2+ Breast Cancer

57-HER-Future-Pathways-to-Better-Care-for-Women-with-HER2-Breast-ROCHE-thumb

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.